Corneal Changes in Estrogen-Dependent Breast Cancer After Hormonal Treatment
Status:
COMPLETED
Trial end date:
2025-01-01
Target enrollment:
Participant gender:
Summary
Aromatase inhibitors (AI) therapy is the treatment of choice for estrogen receptor-positive breast cancer (BC). While AIs effectively suppress tumor growth, estrogen deprivation may have negative impacts on the eyes. This work evaluated the anterior segment changes in estrogen-dependent BC after hormonal treatment.